The problem is especially acute for those with lower health literacy, notes U.S. cardiologist, as experts from both sides of the border call for better education and access to reliable health information.
The 50-minute session will focus on safety concerns with labelling of IV fluids, strategies to mitigate fluoropyrimidine toxicity and the National System for Incident Reporting transition.
A new study explores how 'essentially placebo' treatments raise questions about the transparency and trust that underpin the doctor-patient relationship.
